Concepedia

Author

David Bettoun

Eli Lilly (United States)

Also Known As

David Bettoun, David J. Bettoun

12

Publications

511

Citations

9

H-Index

26

Concepts

All Affiliations

Eli Lilly (United States)Weizmann Institute of ScienceUnited States Military Academy
DB

About

David Bettoun is an author at Eli Lilly (United States) specializing in medicine, developmental biology, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

394

2

Natural Sciences

3

3

155

3

Biochemistry

2

2

67

4

Cell Biology

2

2

271

5

Chemical Biology

1

1

52

David Bettoun

×

9

Publications

510

Citations

9

H-Index

YearCitations

Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis

Ditsa Levanon, Ori Brenner, Varda Negreanu,

Mechanisms of Development

2001

183

Retinoid X Receptor Is a Nonsilent Major Contributor to Vitamin D Receptor-Mediated Transcriptional Activation

David Bettoun, Thomas P. Burris, Keith A. Houck,

Molecular Endocrinology

2003

88

A Vitamin D Receptor-Ser/Thr Phosphatase-p70 S6 Kinase Complex and Modulation of Its Enzymatic Activities by the Ligand

David Bettoun, Donald W. Buck, Jianfen Lu,

Journal of Biological Chemistry

2002

62

Discovery of Novel Cyanamide-Based Inhibitors of Cathepsin C

Dramane I. Lainé, Michael R. Palovich, Brent W. McCleland,

ACS Medicinal Chemistry Letters

2010

52

Interaction between the Androgen Receptor and RNase L Mediates a Cross-talk between the Interferon and Androgen Signaling Pathways

David Bettoun, Angela Scafonas, Su Jane Rutledge,

Journal of Biological Chemistry

2005

37

Phylogenesis and regulated expression of the RUNT domain transcription factors RUNX1 and RUNX3

Ditsa Levanon, Gustavo Glusman, David Bettoun,

Blood Cells Molecules and Diseases

2003

35

Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells

Azriel Schmidt, Michael A. Gentile, Michael Chisamore,

The Journal of Steroid Biochemistry and Molecular Biology

2014

21

Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (<scp>CTI</scp>‐1601) in Friedreich's ataxia

Russell Clayton, Teresa Galas, Noreen Scherer,

Annals of Clinical and Translational Neurology

2024

17

Ligand modulates VDR-Ser/Thr protein phosphatase interaction and p70S6 kinase phosphorylation in a cell-context-dependent manner

David Bettoun, Jianfen Lu, Berket Khalifa,

The Journal of Steroid Biochemistry and Molecular Biology

2004

15

Page 1